Literature DB >> 11750137

Latent infection by bovine herpesvirus type-5 in experimentally infected rabbits: virus reactivation, shedding and recrudescence of neurological disease.

L Caron1, E F Flores, R Weiblen, C F C Scherer, L F Irigoyen, P M Roehe, A Odeon, J H Sur.   

Abstract

Latent infection with bovine herpesvirus type-5 (BHV-5) was established in rabbits inoculated with two South American isolates (EVI-88 and 613) by intranasal or conjunctival routes. Nine rabbits (613, 8/27; EVI-88, 1/34) developed neurological disease and died during acute infection and other three (613, n=2; EVI-88, n=1) developed a delayed neurological disease, at days 34, 41 and 56 post-inoculation (p.i.). Between days 56 and 62 p.i., the remaining rabbits were submitted to five daily administrations of dexamethasone (Dx) to reactivate the infection. Twenty-five out of 44 rabbits (56.8%) shed virus in nasal or ocular secretions after Dx treatment. Virus shedding was first detected at day two post-Dx and lasted from one to 11 days. The highest frequencies of virus reactivation were observed in rabbits inoculated conjunctivally (10/15 versus 15/29); and among rabbits infected with isolate 613 (12/16 versus 13/28). Virus reactivation upon Dx treatment was accompanied by neurological disease in nine rabbits (20.4%), resulting in six deaths (13.6%). Virus in moderate titers and mild to moderate non-suppurative inflammatory changes in the brain characterized the neurological infection. Three other rabbits showed severe neurological signs followed by death after 31 to 54 days of Dx treatment. Virus, viral nucleic acids and inflammatory changes were detected in their brains. The late-onset neurological disease, after acute infection or Dx treatment, was probably a consequence of spontaneous virus reactivation. These results demonstrate that BHV-5 does establish a latent infection in rabbits and that clinical recrudescence may occur upon reactivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750137     DOI: 10.1016/s0378-1135(01)00441-2

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Susceptibility of mice to bovine herpesvirus type 5 infection in the central nervous system.

Authors:  L P Mesquita; R C Costa; M M Fusuma; F R P Bruhn; E Mori; E M Pituco; C M C Mori; R Weiblen; P C Maiorka
Journal:  Vet Res Commun       Date:  2017-09-23       Impact factor: 2.459

2.  An inactivated vaccine from a field strain of bovine herpesvirus-1 (BoHV-1) has high antigenic mass and induces strong efficacy in a rabbit model.

Authors:  Julian Ruiz-Sáenz; Jairo Jaime; Victor Vera
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

3.  Development of a probe based real time PCR assay for detection of bovine herpes virus-1 in semen and other clinical samples.

Authors:  Basavegowdanadoddi Marinaik Chandranaik; Doddamane Rathnamma; S S Patil; Ramesh C Kovi; Jyotsana Dhawan; Shakunigowda Ranganatha; Shrikrishna Isloor; C Renukaprasad; K Prabhudas
Journal:  Indian J Virol       Date:  2012-12-16

4.  Distribution of bovine herpesvirus type 5 DNA in the central nervous systems of latently, experimentally infected calves.

Authors:  Fernanda Silveira Flôres Vogel; Luizinho Caron; Eduardo Furtado Flores; Rudi Weiblen; Evandro Reinoldo Winkelmann; Sandra Vanderli Mayer; Reginaldo Gaspar Bastos
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.